These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. ING5 inhibits cancer aggressiveness via preventing EMT and is a potential prognostic biomarker for lung cancer. Zhang F; Zhang X; Meng J; Zhao Y; Liu X; Liu Y; Wang Y; Li Y; Sun Y; Wang Z; Mei Q; Zhang T Oncotarget; 2015 Jun; 6(18):16239-52. PubMed ID: 25938545 [TBL] [Abstract][Full Text] [Related]
44. The low-abundance transcriptome reveals novel biomarkers, specific intracellular pathways and targetable genes associated with advanced gastric cancer. Bizama C; Benavente F; Salvatierra E; Gutiérrez-Moraga A; Espinoza JA; Fernández EA; Roa I; Mazzolini G; Sagredo EA; Gidekel M; Podhajcer OL Int J Cancer; 2014 Feb; 134(4):755-64. PubMed ID: 23907728 [TBL] [Abstract][Full Text] [Related]
45. Versican V1 Overexpression Induces a Myofibroblast-Like Phenotype in Cultured Fibroblasts. Carthy JM; Meredith AJ; Boroomand S; Abraham T; Luo Z; Knight D; McManus BM PLoS One; 2015; 10(7):e0133056. PubMed ID: 26176948 [TBL] [Abstract][Full Text] [Related]
46. Genetic determinants of pemetrexed responsiveness and nonresponsiveness in non-small cell lung cancer cells. Wu MF; Hsiao YM; Huang CF; Huang YH; Yang WJ; Chan HW; Chang JT; Ko JL J Thorac Oncol; 2010 Aug; 5(8):1143-51. PubMed ID: 20559153 [TBL] [Abstract][Full Text] [Related]
47. Overexpression of kinesins mediates docetaxel resistance in breast cancer cells. De S; Cipriano R; Jackson MW; Stark GR Cancer Res; 2009 Oct; 69(20):8035-42. PubMed ID: 19789344 [TBL] [Abstract][Full Text] [Related]
48. miR-215 promotes malignant progression of gastric cancer by targeting RUNX1. Li N; Zhang QY; Zou JL; Li ZW; Tian TT; Dong B; Liu XJ; Ge S; Zhu Y; Gao J; Shen L Oncotarget; 2016 Jan; 7(4):4817-28. PubMed ID: 26716895 [TBL] [Abstract][Full Text] [Related]
49. CEBPD amplification and overexpression in urothelial carcinoma: a driver of tumor metastasis indicating adverse prognosis. Wang YH; Wu WJ; Wang WJ; Huang HY; Li WM; Yeh BW; Wu TF; Shiue YL; Sheu JJ; Wang JM; Li CF Oncotarget; 2015 Oct; 6(31):31069-84. PubMed ID: 26307680 [TBL] [Abstract][Full Text] [Related]
50. Global characterization of signalling networks associated with tamoxifen resistance in breast cancer. Browne BC; Hochgräfe F; Wu J; Millar EK; Barraclough J; Stone A; McCloy RA; Lee CS; Roberts C; Ali NA; Boulghourjian A; Schmich F; Linding R; Farrow L; Gee JM; Nicholson RI; O'Toole SA; Sutherland RL; Musgrove EA; Butt AJ; Daly RJ FEBS J; 2013 Nov; 280(21):5237-57. PubMed ID: 23876235 [TBL] [Abstract][Full Text] [Related]
51. TGFBI Expression in Cancer Stromal Cells is Associated with Poor Prognosis and Hematogenous Recurrence in Esophageal Squamous Cell Carcinoma. Ozawa D; Yokobori T; Sohda M; Sakai M; Hara K; Honjo H; Kato H; Miyazaki T; Kuwano H Ann Surg Oncol; 2016 Jan; 23(1):282-9. PubMed ID: 25448803 [TBL] [Abstract][Full Text] [Related]
52. Differential expression of versican isoforms is a component of the human melanoma cell differentiation process. Domenzain C; Docampo MJ; Serra M; Miquel L; Bassols A Biochim Biophys Acta; 2003 Sep; 1642(1-2):107-14. PubMed ID: 12972299 [TBL] [Abstract][Full Text] [Related]
53. Identification of genes involved in resistance to interferon-alpha in cutaneous T-cell lymphoma. Tracey L; Villuendas R; Ortiz P; Dopazo A; Spiteri I; Lombardia L; Rodríguez-Peralto JL; Fernández-Herrera J; Hernández A; Fraga J; Dominguez O; Herrero J; Alonso MA; Dopazo J; Piris MA Am J Pathol; 2002 Nov; 161(5):1825-37. PubMed ID: 12414529 [TBL] [Abstract][Full Text] [Related]
54. SNF5 deficiency induces apoptosis resistance by repressing SATB1 expression in Sézary syndrome. Li Y; Wang J; Yu M; Wang Y; Zhang H; Yin J; Li Z; Li T; Yan H; Li F; Wang X Leuk Lymphoma; 2018 Oct; 59(10):2405-2413. PubMed ID: 29334836 [TBL] [Abstract][Full Text] [Related]
55. Expression and localization of versican during postnatal development of rat temporomandibular joint disc. Toriya N; Takuma T; Arakawa T; Abiko Y; Sasano Y; Takahashi I; Sakakura Y; Rahemtulla F; Mizoguchi I Histochem Cell Biol; 2006 Mar; 125(3):205-14. PubMed ID: 16187070 [TBL] [Abstract][Full Text] [Related]
56. TPD7 inhibits the growth of cutaneous T cell lymphoma H9 cell through regulating IL-2R signalling pathway. Zhu M; Yang L; Shi X; Gong Z; Yu R; Zhang D; Zhang Y; Ma W J Cell Mol Med; 2020 Jan; 24(1):984-995. PubMed ID: 31742861 [TBL] [Abstract][Full Text] [Related]
57. Classification and prediction of survival in patients with the leukemic phase of cutaneous T cell lymphoma. Kari L; Loboda A; Nebozhyn M; Rook AH; Vonderheid EC; Nichols C; Virok D; Chang C; Horng WH; Johnston J; Wysocka M; Showe MK; Showe LC J Exp Med; 2003 Jun; 197(11):1477-88. PubMed ID: 12782714 [TBL] [Abstract][Full Text] [Related]
58. Aurora Kinase A Is Upregulated in Cutaneous T-Cell Lymphoma and Represents a Potential Therapeutic Target. Humme D; Haider A; Möbs M; Mitsui H; Suárez-Fariñas M; Ohmatsu H; Isabell Geilen C; Eberle J; Krueger JG; Beyer M; Hummel M; Anagnostopoulos I; Sterry W; Assaf C J Invest Dermatol; 2015 Sep; 135(9):2292-2300. PubMed ID: 25848977 [TBL] [Abstract][Full Text] [Related]
59. CD26 expression on T-anaplastic large cell lymphoma (ALCL) line Karpas 299 is associated with increased expression of versican and MT1-MMP and enhanced adhesion. Havre PA; Dang LH; Ohnuma K; Iwata S; Morimoto C; Dang NH BMC Cancer; 2013 Nov; 13():517. PubMed ID: 24180670 [TBL] [Abstract][Full Text] [Related]
60. Correlation of Versican Expression, Accumulation, and Degradation during Embryonic Development by Quantitative Immunohistochemistry. Snyder JM; Washington IM; Birkland T; Chang MY; Frevert CW J Histochem Cytochem; 2015 Dec; 63(12):952-67. PubMed ID: 26385570 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]